This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cutting edge events and insight about the convergence of technology and medicine.

Artificial intelligence's potential role in the revolution of drug discovery - WHITEPAPER

ArticleImage

Download the exclusive whitepaper

Modern drug discovery is a complicated process that requires identification of disease targets, bioactive substances that act upon those targets, and finally optimization of those drug candidates. Each stage of the process is time consuming and costly with no guarantee of success. The average drug requires $2.5 billion to reach FDA approval and only a tenth of all drugs that reach phase I clinical trial ultimately succeed. Artificial intelligence (AI) promises to revolutionize this costly and inefficient discovery process.

This whitepaper will explore AI's potential impact in modern drug discovery, including:

  • Datasets for AI

  • Using AI to discover/ design novel therapeutics

  • Challenges in the application of AI in drug discovery

  • How AI can be used to improve current therapeutics

  • The convergence of Big Data and machine learning


To download the exclusive whitepaper simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.

Have any questions about the whitepaper or interested in sponsoring a future whitepaper? Email andrew.burrows@informa.com.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.